Rapidly Progressive Dementia Including Prion Disease
Conditions
Interventions
prion diseases
Sponsors
Nagasaki University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients visiting the Department of Neurology at each research university between the date of approval by the institutional director of each research center and March 31, 2023. (2) Target diseases: Prion diseases (Creutzfeldt-Jakob disease (CJD), Gerstmann-Streicher-Scheinker syndrome (GSS), fatal familial insomnia (FFI)), epilepsy, neurodegenerative diseases including Alzheimer's disease, rapidly progressive dementia, and healthy subjects (3) Patients who have been fully informed about the participation in this study and who have given their (or their surrogate's) free written consent based on their full understanding of the study. Translated with www.DeepL.com/Translator (free version)
Exclusion criteria
Exclusion criteria: Patients who fall under any one of the following will be excluded from the study. (1) When the research subject and the research subject (or a surrogate) request discontinuation of the study within the period of hospitalization. (2) Other patients deemed inappropriate as research subjects by the investigators, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity and specificity of prion and synuclein seeding activities from hair and its roots | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in sensitivity from the timing | — |
Countries
Japan
Contacts
Public ContactKatsuya Satoh
Nagasaki University Department of Health Sciences, Unit of Medical and Dental Sciences
Outcome results
None listed